MedPath
HSA Approval

TELSTAN 40 TABLET 40 mg

SIN14614P

TELSTAN 40 TABLET 40 mg

TELSTAN 40 TABLET 40 mg

September 12, 2014

THINQ PHARMA - CRO PRIVATE LIMITED

THINQ PHARMA - CRO PRIVATE LIMITED

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantTHINQ PHARMA - CRO PRIVATE LIMITED
Licence HolderTHINQ PHARMA - CRO PRIVATE LIMITED

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET

ORAL

Medical Information

C09CA07

telmisartan

Manufacturer Information

THINQ PHARMA - CRO PRIVATE LIMITED

Alembic Pharmaceuticals Limited (Formulation Division)

Active Ingredients

Telmisartan

40 mg

Telmisartan

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

TELSTAN 40 TABLET 40 mg - HSA Approval | MedPath